The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium 2-(4-methoxy-2-nitrophenylcarbamoyl)benzoate ID: ALA4171448
PubChem CID: 145949208
Max Phase: Preclinical
Molecular Formula: C15H11N2NaO6
Molecular Weight: 316.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=O)c2ccccc2C(=O)[O-])c([N+](=O)[O-])c1.[Na+]
Standard InChI: InChI=1S/C15H12N2O6.Na/c1-23-9-6-7-12(13(8-9)17(21)22)16-14(18)10-4-2-3-5-11(10)15(19)20;/h2-8H,1H3,(H,16,18)(H,19,20);/q;+1/p-1
Standard InChI Key: JXNDWTQIHFLCEH-UHFFFAOYSA-M
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
13.2477 -12.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8402 -13.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2477 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8402 -14.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0210 -14.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6136 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0210 -13.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0668 -12.4911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8402 -11.7833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0668 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4743 -13.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4743 -14.6185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2934 -13.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7050 -12.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5241 -12.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9316 -13.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5241 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7050 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2934 -11.7833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7050 -11.0755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4743 -11.7833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7507 -13.2030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1623 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9344 -11.7008 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
10 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
19 20 2 0
19 21 1 0
14 19 1 0
22 23 1 0
16 22 1 0
11 13 1 0
3 10 1 0
M CHG 4 9 -1 19 1 21 -1 24 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 316.27Molecular Weight (Monoisotopic): 316.0695AlogP: 2.55#Rotatable Bonds: 5Polar Surface Area: 118.77Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.91CX Basic pKa: ┄CX LogP: 2.51CX LogD: -0.98Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.65Np Likeness Score: -1.34
References 1. Sirajuddin M, McKee V, Tariq M, Ali S.. (2018) Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations., 143 [PMID:29133050 ] [10.1016/j.ejmech.2017.11.001 ]